Rtw Investments, LP Aquestive Therapeutics, Inc. Transaction History
Rtw Investments, LP
- $7.48 Billion
- Q3 2025
A detailed history of Rtw Investments, LP transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 6,250,000 shares of AQST stock, worth $33.7 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
6,250,000Holding current value
$33.7 Million% of portfolio
0.47%Shares
1 transactions
Others Institutions Holding AQST
# of Institutions
162Shares Held
65.9MCall Options Held
794KPut Options Held
457K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$52.9 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.66MShares$30.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$29.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$20.3 Million0.05% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.63MShares$14.1 Million1.1% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $288M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...